Immunology and immunotherapy of cholangiocarcinoma
Cholangiocarcinoma is the second most common primary liver cancer. Its incidence is low in
the Western world but is rising globally. Surgery, chemotherapy and radiation therapy have …
the Western world but is rising globally. Surgery, chemotherapy and radiation therapy have …
Immunology and immunotherapy of cholangiocarcinoma
TF Greten, R Schwabe, N Bardeesy… - Nature reviews …, 2023 - pubmed.ncbi.nlm.nih.gov
Cholangiocarcinoma is the second most common primary liver cancer. Its incidence is low in
the Western world but is rising globally. Surgery, chemotherapy and radiation therapy have …
the Western world but is rising globally. Surgery, chemotherapy and radiation therapy have …
Immunology and immunotherapy of cholangiocarcinoma
TF Greten, R Schwabe, N Bardeesy… - Nature Reviews …, 2023 - search.proquest.com
Cholangiocarcinoma is the second most common primary liver cancer. Its incidence is low in
the Western world but is rising globally. Surgery, chemotherapy and radiation therapy have …
the Western world but is rising globally. Surgery, chemotherapy and radiation therapy have …
Immunology and immunotherapy of cholangiocarcinoma.
TF Greten, R Schwabe, N Bardeesy, L Ma… - Nature reviews …, 2023 - europepmc.org
Cholangiocarcinoma is the second most common primary liver cancer. Its incidence is low in
the Western world but is rising globally. Surgery, chemotherapy and radiation therapy have …
the Western world but is rising globally. Surgery, chemotherapy and radiation therapy have …